• Sections
  • Newsletters
  • Podcasts
  • Support TPM
  • Shop Merch
  • Site Info
  • About
  • Sections
  • Editors' Blog
  • News
  • Live Blog
  • Cafe
  • Muckraker
  • Morning Memo
  • Where Things Stand
  • The Weekender
  • The Franchise
  • Features
  • Support TPM
  • Memberships
  • The TPM Journalism Fund
  • Site Info
  • FAQ
  • Contact
  • Advertise
  • Terms
  • Privacy
  • Site Status
  • About
  • About TPM
  • Mission
  • Masthead
  • Financials
  • Careers
  • Pitch Us
Follow TPM
© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.
Talking Points Memo Logo
Send Tips TPM 25th Anniversary Badge
COVID-19
HHS Denies It’s Scaling Back COVID Testing Because Of White House Pressure
By Josh Kovensky
08.26.20 | 4:06 pm
Attendees At FLOTUS’ RNC Speech Not Required To Take COVID-19 Tests
By Cristina Cabrera
08.26.20 | 7:41 am
Navarro Dismisses Criticism Of Plasma Treatment For COVID-19 As ‘Crazy Talking Point’
By Summer Concepcion
08.25.20 | 1:43 pm
FDA Chief Admits He Overhyped Plasma Treatment Against COVID: ‘Criticism Is Entirely Justified’
By Cristina Cabrera
08.25.20 | 8:31 am
BETHESDA, MD - NOVEMBER 21: Nurse Floreliz Mendoza holds the syringe she has used to inject Andie Vaught, 25, with an experimental Zika vaccine as part of a clinical trial at the National Institute of Health Clinical Center in Bethesda, Maryland, November 21, 2016. This vaccine, one of about six or seven in different phases of clinical trial, is currently undergoing safety testing at three locations in the country. Instead of using dead or weakened virus to get the immune system to recognize the infection and fight it off, it uses a piece of DNA engineered to contain genes that code for proteins of the Zika virus. (Photo by Allison Shelley/For The Washington Post) BETHESDA, MD - NOVEMBER 21: Nurse Floreliz Mendoza holds the syringe she has used to inject Andie Vaught, 25, with an experimental Zika vaccine as part of a clinical trial at the National Institute of Health Clinical Center in Bethesda, Maryland, November 21, 2016. This vaccine, one of about six or seven in different phases of clinical trial, is currently undergoing safety testing at three locations in the country. Instead of using dead or weakened virus to get the immune system to recognize the infection and fight it off, it uses a piece of DNA engineered to contain genes that code for proteins of the Zika virus. (Photo by Allison Shelley/For The Washington Post)
Why Trump’s Pressure Campaign On The FDA Will Damage Any COVID-19 Vaccine To Come
By Josh Kovensky
08.24.20 | 6:05 pm
Conservative Ohio Reps Mount Impeachment Bid Against GOP Guv Who Took COVID Seriously
By Kate Riga
08.24.20 | 12:44 pm
WH Adviser Berated FDA Officials For Not Approving COVID-19 Therapeutics ‘On Trump Time’
By Cristina Cabrera
08.24.20 | 8:59 am
Trump Will Announce Emergency Authorization For COVID-19 Plasma Treatment
By Jonathan Lemire and MIKE STOBBE
08.23.20 | 3:41 pm
Trump Baselessly Accuses ‘Deep State’ At FDA Of Delaying Clinical Trials For COVID Vaccine
By Zoe Richards
08.22.20 | 5:52 pm
Top Vaccine Official Says He’ll Resign If FDA Caves To Political Pressure
By Josh Kovensky
08.21.20 | 11:22 am
Next →
Talking Points Memo
© 2026 TPM MEDIA LLC.
Masthead Contact Privacy Policy
  • About
  • Memberships
  • Careers
  • Advertise
  • Site Status
  • FAQ
  • Newsletters
  • Pitch Us
  • Terms of Use
  • CCPA Notice